DI GIANNANTONIO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 19.343
EU - Europa 10.413
AS - Asia 9.359
SA - Sud America 1.598
Continente sconosciuto - Info sul continente non disponibili 996
AF - Africa 172
OC - Oceania 19
Totale 41.900
Nazione #
US - Stati Uniti d'America 18.901
SG - Singapore 3.639
IT - Italia 2.989
CN - Cina 2.383
IE - Irlanda 1.333
BR - Brasile 1.290
RU - Federazione Russa 1.127
UA - Ucraina 1.092
TR - Turchia 1.085
VN - Vietnam 936
SE - Svezia 894
GB - Regno Unito 784
DE - Germania 701
FR - Francia 477
IN - India 414
FI - Finlandia 320
CA - Canada 224
HK - Hong Kong 221
AT - Austria 159
BD - Bangladesh 107
AR - Argentina 105
MX - Messico 103
ES - Italia 97
NL - Olanda 97
KR - Corea 94
JP - Giappone 86
PL - Polonia 67
ZA - Sudafrica 66
IQ - Iraq 59
EC - Ecuador 54
ID - Indonesia 49
GR - Grecia 46
CO - Colombia 45
BE - Belgio 43
PK - Pakistan 38
CZ - Repubblica Ceca 33
EU - Europa 28
IR - Iran 26
LT - Lituania 25
CH - Svizzera 23
PH - Filippine 23
VE - Venezuela 23
CL - Cile 22
CR - Costa Rica 22
SA - Arabia Saudita 22
HU - Ungheria 21
KE - Kenya 21
EG - Egitto 19
UZ - Uzbekistan 19
AE - Emirati Arabi Uniti 18
JM - Giamaica 18
MA - Marocco 18
RO - Romania 18
JO - Giordania 17
MY - Malesia 17
PY - Paraguay 17
AU - Australia 15
HN - Honduras 15
IL - Israele 15
PE - Perù 15
GT - Guatemala 12
BO - Bolivia 11
TT - Trinidad e Tobago 11
UY - Uruguay 11
DZ - Algeria 10
EE - Estonia 10
TN - Tunisia 10
TW - Taiwan 10
DK - Danimarca 9
AZ - Azerbaigian 8
KZ - Kazakistan 7
NI - Nicaragua 7
RS - Serbia 7
SV - El Salvador 7
BH - Bahrain 6
LB - Libano 6
MD - Moldavia 6
NG - Nigeria 6
OM - Oman 6
PT - Portogallo 6
TH - Thailandia 6
BB - Barbados 5
BG - Bulgaria 5
CG - Congo 5
DO - Repubblica Dominicana 5
HR - Croazia 5
KG - Kirghizistan 5
SY - Repubblica araba siriana 5
AL - Albania 4
AM - Armenia 4
ET - Etiopia 4
KW - Kuwait 4
PS - Palestinian Territory 4
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GE - Georgia 3
GY - Guiana 3
LK - Sri Lanka 3
LV - Lettonia 3
NP - Nepal 3
Totale 40.883
Città #
Singapore 2.673
San Jose 2.050
Chandler 1.711
Jacksonville 1.422
Dublin 1.317
Ashburn 1.199
Council Bluffs 781
Dallas 683
Princeton 675
Beijing 565
Southend 461
Izmir 457
Los Angeles 431
Nanjing 423
The Dalles 368
Santa Clara 339
Ho Chi Minh City 308
New York 295
Altamura 282
Wilmington 276
Dearborn 246
Rome 233
Cambridge 222
Hong Kong 201
Munich 201
Hanoi 193
Buffalo 180
Chieti 177
Nanchang 170
Milan 161
Boardman 146
Vienna 140
Tongling 137
São Paulo 130
Ann Arbor 127
Redondo Beach 123
Moscow 112
Phoenix 103
Orem 94
Atlanta 92
Shenyang 88
Woodbridge 81
Washington 80
Denver 76
Brooklyn 73
Tokyo 71
Montreal 70
Chicago 68
Houston 68
Grevenbroich 64
Hebei 64
Columbus 62
Kunming 61
Toronto 61
Da Nang 60
Tianjin 59
San Francisco 58
London 57
Helsinki 56
Mount Pleasant 54
Pescara 52
Turku 52
Hefei 50
Warsaw 49
Boston 48
Johannesburg 48
Dong Ket 46
Jiaxing 46
Nuremberg 46
Changsha 45
Norwalk 43
Chennai 42
Brussels 41
Stockholm 41
Frankfurt am Main 40
Seattle 39
Seoul 39
Bologna 38
Florence 37
Hangzhou 37
Rio de Janeiro 37
Memphis 36
Belo Horizonte 35
Haiphong 34
Manchester 34
Mexico City 34
Camerino 33
Falls Church 33
Ankara 32
Mumbai 27
Brasília 26
Jinan 26
Kimball 26
Lanzhou 26
Pune 26
Silver Spring 26
Padova 25
Palermo 25
Romola 25
Paris 24
Totale 22.704
Nome #
The benzydamine experience: a systematic review of benzydamine abuse 1.131
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 610
Alexithymia and suicide risk in psychiatric disorders: A mini-review 537
“Purple Drank” (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications 517
Misuse of Anticholinergic Medications: A Systematic Review 486
La schizofrenia incipiente. Un saggio di analisi gestaltica del delirio 421
The Italian version of the Obsessive-Compulsive Drinking Scale: Validation, comparison with the other versions, and difference between type 1- and type 2-like alcoholics 261
L’ossessione del mangiare sano: la misurazione dell’ortoressia nervosa attraverso la scala ortho-15 259
Vortioxetine and Aripiprazole Combination in Treatment-Resistant Obsessive-Compulsive Disorder: A Case Report 242
Alessitimia, lamentele somatiche e sintomi depressivi in adolescenza: risultati preliminari di uno studio longitudinale 232
Transcranial Direct Current Stimulation in Substance Use Disorders: A Systematic Review of Scientific Literature 219
Resilience and cross-network connectivity: A neural model for post-trauma survival 213
Passioni della mente e della storia. Protagonisti e teorie della psichiatria italiana tra '800 e '900. 210
Exploring dopaminergic transmission in gambling addiction: A systematic translational review 208
Craving Typology Questionnaire (CTQ): A scale for alcohol craving in normal controls and alcoholics 206
The bridge between two worlds: Psychoanalysis and fMRI 194
Psicopatologia in slides 190
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 189
Alcohol drinking patterns in young people: A survey-based study 189
Aggression, impulsivity, personality traits, and childhood trauma of prisoners with substance abuse and addiction 187
Hallucinogen persisting perception disorder: Etiology, clinical features, and therapeutic perspectives 182
A case of resistant schizophrenia successfully treated with clozapine/long-acting injectable aripiprazole combination 180
The role of inhaled loxapine in the treatment of acute agitation in patients with psychiatric disorders: A clinical review 179
Agomelatine Effectiveness, Tolerability, and Impact on Anhedonia in Major Depression: A Pooled Analysis 176
Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects. 175
Transcranial Direct Current Stimulation Reduces Craving in Substance Use Disorders: A Double-blind, Placebo-Controlled Study 174
Euthymic bipolar disorder patients and EEG microstates: a neural signature of their abnormal self experience? 173
A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015 171
Gambling disorder: Clinical, preventive and organizational implications 171
Late-Life Depression: Modifications of Brain Resting State Activity 170
Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries 169
A bibliometric analysis of scientific production on atypical antipsychotic drugs from Italy 168
Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza 168
Neural correlates of negative emotion processing in bipolar disorder 166
Body representations and basic symptoms in schizophrenia 166
Binding action and emotion in first-episode schizophrenia 164
Cognitive dynamics of intertemporal choice in gambling disorder 164
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 163
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. 163
Psoriasis and Alexithymia 161
The novel antipsychotic cariprazine (RGH-188): State-of-the-art in the treatment of psychiatric disorders 160
Substance Use in the Club Scene of Rome: A Pilot Study 160
Bipolar disorder with and without a history of psychotic features: fMRI correlates of sustained attention 160
Pharmacological treatments in gambling disorder: A qualitative review 160
Characterizing the building blocks of Problematic Use of the Internet (PUI): The role of obsessional impulses and impulsivity traits among Italian young adults 160
An update of safety of clinically used atypical antipsychotics 159
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder: A Pilot Study 158
Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials 157
The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature 157
Novel psychoactive substances: Use and knowledge among adolescents and young adults in urban and rural areas 157
Depressive symptoms in adolescence: the role of gender and personality traits 156
La persona dello schizofrenico. Uno studio clinico, psicologico, antropofenomenologico 156
Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review 154
Integrative processing of touch and affect in social perception: An fMRI study 154
The role of cholesterol levels in mood disorders and suicide 154
A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. 153
Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion 153
Augmentation con aripiprazolo nella depressione maggiore resistente al trattamento: risultati preliminari di uno studio in aperto con dose fissa 152
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 152
Functional magnetic resonance imaging of internet addiction in young adults 152
Relationship between craving and plasma leptin concentrations in patients with cocaine addiction 152
Novel psychoactive substances in young adults with and without psychiatric comorbidities 152
Current and future perspectives on the major depressive disorder: Focus on the new multimodal antidepressant vortioxetine 151
Disrupted relationship between "resting state" connectivity and task-evoked activity during social perception in schizophrenia 151
Alexithymia and suicide risk among patients with schizophrenia: preliminary findings of a cross-sectional study 150
Aggiunta di memantina alla terapia corrente con donezepil in pazienti con demenza di Alzheimer: effetto sui sintomi psicologici e comportamentali associati alla demenza 150
Alexithymia, suicide risk and serum lipid levels among adult outpatients with panic disorder 150
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives 148
Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis 148
Substance Use in Schizophrenia: Efficacy of Atypical Antipsychotics 147
Modifications in resting state functional anticorrelation between default mode network and dorsal attention network: comparison among young adults, healthy elders and mild cognitive impairment patients 147
Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence 147
BDNF concentration and impulsiveness level in post-traumatic stress disorder 147
New drugs on the internet: The case of Camfetamine 146
Treatment of antipsychotic-induced hyperprolactinemia: An update on the role of the dopaminergic receptors D2 partial agonist aripiprazole 146
Body-environment integration: Temporal processing of tactile and auditory inputs along the schizophrenia continuum 146
Inflammatory markers and suicidal attempts in depressed patients: A review 145
Dopamine and norepinephrine content in rat carotid body after chronic hypoxia and hyperoxia 144
Emerging mania following escitalopram withdrawal in a patient with unipolar depression managed with its reintroduction 144
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 143
Creativity and psychiatric illness: A functional perspective beyond chaos 143
Gambling and suicide: The socio-anthropological perspective 143
Aggiunta di memantina alla terapia corrente con donepezil in pazienti con demenza di Alzheimer: effetto sui sintomi psicologici e comportamentali associati alla demenza 142
C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis 142
Transcranial Electrical and Magnetic Stimulation (tES and TMS) for Addiction Medicine: A consensus paper on the present state of the science and the road ahead 142
Premenstrual Dysphoric Disorder Without Comorbid Psychiatric Conditions: A Systematic Review of Therapeutic Options 141
Gambling disorder and bilateral transcranial direct current stimulation: A case report 141
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 140
Cytokines and the brain 139
Aspetti psicodinamici degli esordi psicotici con manifestazioni violente ed aggressive 139
Sudden cardiac death related to antipsychotics: Beyond the long QT syndrome hypothesis 138
Upcoming tactile events and body ownership in schizophrenia 137
Major depressive disorder, anhedonia and agomelatine: an open-label study. 136
TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior 136
Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study 136
Alessitimia, lamentele somatiche e sintomi depressivi in adolescenza: risultari preliminari di uno studio longitudinale 135
Pregabalin Abuse and Addiction 135
Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers. 135
A comprehensive review on the efficacy of S-adenosyl-L-Methionine in major depressive disorder 133
A Light in the Darkness: Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat the Hedonic Dysregulation of Addiction 133
Totale 18.948
Categoria #
all - tutte 168.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.455 0 0 0 173 137 47 70 123 130 58 184 533
2022/20234.843 438 724 285 500 461 917 287 363 552 74 139 103
2023/20242.341 175 111 165 90 126 658 480 115 51 84 78 208
2024/20255.921 371 1.022 804 170 110 281 333 375 551 423 708 773
2025/202612.487 925 474 1.353 1.747 1.077 745 1.898 842 1.324 1.021 766 315
2026/20274.935 1.086 1.713 1.138 998 0 0 0 0 0 0 0 0
Totale 41.900